Entero Healthcare Solutions has received approval from Board of Directors for execution of definitive agreements for acquiring 80% stake in Bioaide Technologies (Bioaide). The business of Bioaide is in line with the business of the Company i.e. wholesale distribution of medical devices and other allied products. The acquisition shall be completed by February 15, 2026.
The company has also received approval for entering into a binding Memorandum of Understanding for acquiring 51% stake in Anand Chemiceutics, subject to satisfactory completion of due diligence and execution of the definitive agreements. The Board of Directors of the Company, at its meeting held on November 12,2025, inter alia, considered and approved the same.
Entero Healthcare Solutions is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
| Company Name | CMP |
|---|---|
| Redington | 222.80 |
| Adani Enterprises | 2505.65 |
| Amrapali Industries | 18.21 |
| Rashi Peripheral | 530.50 |
| PDS | 300.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: